ZandCellZandCell
  • HOME
  • About
    • About
    • News Releases
  • Programs
  • Science
  • Apply
  • Contact
  • Login

    Lost your password?

  • 0
    Cart
  1. Home
  2. B. C. girl with leukemia seeks Christmas stem cell donor – DigitalJournal.com
  3. NEWS

NEWS

CAR T Cell Therapy Market is Expected to Grow at the CAGR of 5.96% During 2017-2025: Credence Research – GlobeNewswire (press release)

CAR T Cell Therapy Market is Expected to Grow at the CAGR of 5.96% During 2017-2025: Credence ResearchGlobeNewswire (press release)SAN JOSE, Calif., April 02, 2018 (GLOBE NEWSWIRE) — The latest market report published by Credence Research, Inc. “CAR … Continue reading

2018-04-02 Michael Zand NEWS

CAR T Cell Therapy Market is Expected to Grow at the CAGR of 5.96% During 2017-2025: Credence Research – GlobeNewswire (press release)

CAR T Cell Therapy Market is Expected to Grow at the CAGR of 5.96% During 2017-2025: Credence ResearchGlobeNewswire (press release)SAN JOSE, Calif., April 02, 2018 (GLOBE NEWSWIRE) — The latest market report published by Credence Research, Inc. “CAR … Continue reading

2018-04-02 Michael Zand NEWS

A Flawed Study Shows How Little We Understand Crispr’s Effects – WIRED

Continue reading

2018-04-02 Michael Zand NEWS

A Flawed Study Shows How Little We Understand Crispr’s Effects – WIRED


WIRED

A Flawed Study Shows How Little We Understand Crispr’s Effects
WIRED
But that doesn’t mean that Crispr has been given the all-clear. The now-retracted paper claimed that Crispr caused nearly 2,000 unexpected mutations—ten times previously observed off-target rates—in two mice that it cured of blindness. But just as …
Research Suggesting CRISPR Is Dangerous Is Retracted After Authors Disprove Their Own ResultsIFLScience
CRISPR food in grocery stores in 5 years? Gene editing research picks up speedGenetic Literacy Project

all 13 news articles »

Continue reading

2018-04-02 Michael Zand NEWS

Synlogic Doses First Patient in Phase 1b/2a Trial of SYNB1020 for Treatment of Hyperammonemia in Patients with … – Markets Insider

Synlogic Doses First Patient in Phase 1b/2a Trial of SYNB1020 for Treatment of Hyperammonemia in Patients with …Markets InsiderSynlogic (Nasdaq:SYBX), a clinical-stage company applying synthetic biology to probiotic bacteria to develop novel living m… Continue reading

2018-04-02 Michael Zand NEWS

Synlogic (SYBX) Doses First Patient in Phase 1b/2a Trial of SYNB1020 – StreetInsider.com

Synlogic (SYBX) Doses First Patient in Phase 1b/2a Trial of SYNB1020StreetInsider.comSynlogic (Nasdaq:SYBX), a clinical-stage company applying synthetic biology to probiotic bacteria to develop novel living medicines, announced that the first patient w… Continue reading

2018-04-02 Michael Zand NEWS

CRISPR enhances gene therapy to fight inherited diseases – Medical Xpress

Medical XpressCRISPR enhances gene therapy to fight inherited diseasesMedical XpressBut the advent of CRISPR gene-editing technology has changed that. While not perfect, CRISPR is a precise method to edit the genome and is user-friendly compared with o… Continue reading

2018-04-02 Michael Zand NEWS

Growing Industry of Cancer Immunotherapy Market is Estimated to grow at a healthy CAGR of 14.8% and reach till USD … – Medgadget (blog)

Growing Industry of Cancer Immunotherapy Market is Estimated to grow at a healthy CAGR of 14.8% and reach till USD …Medgadget (blog)Some cancers are resistant to surgery and immunotherapy either due to difficult anatomical positions which can be fata… Continue reading

2018-04-02 Michael Zand NEWS
  • 1
  • …
  • 315
  • 316
  • 317
  • 318
  • 319
  • …
  • 3,595
Recent Posts
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Шведская компания ZandCell поставит 160 млн доз вакцины от COVID-19 в несколько стран мира 2021-07-22
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
About Us

ZandCell is a biotechnology company pioneering the advancements and therapeutic applications of Stem Cell Therapy. Our Technology is called “Regenerate”.

SiteLock
Contact Info
+1-702-425-9049
+46-736-779970
info@zandcell.com
Find us on map


Latest News
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Official PayPal Seal


© 2024 ZandCell. All Rights Reserved.
  • About
  • Programs
  • Science
  • Privacy Policy
  • Contact
  • RSS
  • Send us email
  • Follow us on Twitter
  • Follow us on Facebook
  • Follow Us on Linkedin
  • Call us via Skype
  • Follow Us on Instagram
  • Subscribe our YouTube Channel
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.

WIRED

A Flawed Study Shows How Little We Understand Crispr’s Effects
WIRED
But that doesn’t mean that Crispr has been given the all-clear. The now-retracted paper claimed that Crispr caused nearly 2,000 unexpected mutations—ten times previously observed off-target rates—in two mice that it cured of blindness. But just as …
Research Suggesting CRISPR Is Dangerous Is Retracted After Authors Disprove Their Own ResultsIFLScience
CRISPR food in grocery stores in 5 years? Gene editing research picks up speedGenetic Literacy Project

all 13 news articles »